OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.
BACKGROUND
Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy.


METHODS
Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected.


RESULTS
Initial response rates were 83.5 percent and long-term response rates were 76.3 percent.


CONCLUSIONS
Initial and the long-term response rate were equally good for lymphangioma.
Yoo
Jae Chul
JC
Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea.
Ahn
Youngjin
Y
Lim
Yune Syung
YS
Hah
J Hun
JH
Kwon
Tack-Kyun
TK
Sung
Myung-Whun
MW
Kim
Kwang Hyun
KH
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007223:Infant; D008202:Lymphangioma / Q000628:therapy*; D008297:Male; D010844:Picibanil / Q000627:therapeutic use*; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy / Q000379:methods*
D012597:Sclerosing Solutions; D010844:Picibanil